Can-GARD/CCMG – The Leading Strand Series June 2023

Loading Events

This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers, clinicians and innovators.  The series will help attendees anticipate, access, and apply new approaches and technologies for patient care.

Click HERE to register.

CCMG Position Statement: Genetic And Metabolic Investigations For Patients With Neurodevelopmental Disorders

The co-chairs of the CCMG working group to develop a guideline for genetic and metabolic investigations for patients with NDDs will discuss the process and results. A national multidisciplinary working group developed a position statement for the genetic and metabolic investigation of patients with neurodevelopmental disorders (NDDs). The impetus for this guideline, the methodology and process for its development and key recommendations will be presented.

Learning Objectives:

  • Understand the impetus for a Canadian guideline for genetic and metabolic investigation of neurodevelopmental disorders (NDDs)
  • Describe and apply methodologies for guideline development
  • Plan an investigation for patients with neurodevelopmental disorders


Dr. Melissa Carter
Dr. Hilary Vallance



Dr. Melissa Carter is a clinical geneticist at CHEO in Ottawa, specializing in neurodevelopmental disorders. She completed her residency in Ottawa and then a fellowship in developmental pediatrics in Toronto. She is the co-chair of a CCMG working group to develop guidelines for etiological investigations for patients with neurodevelopmental disorders, and is currently the Clinical Lead of the Neurodevelopmental Genetics expert group at Ontario Health.



Dr. Hilary Vallance is a Medical Biochemist / Biochemical Geneticist at BC Children’s Hospital who obtained her MD from the University of British Columbia (UBC). She completed a residency in Medical Biochemistry at UBC followed by fellowship training in Biochemical Genetics. She is the Director of the BC Newborn Screening Program. Her research contributions have been in the area of inborn errors of metabolism and newborn screening for treatable conditions.



September 23
October 28
November 25
December 16
January 27
February 24
March 31
April 28
May 26
June 30

Click HERE to register.

Go to Top